| NDC Code | 0173-0893-14 |
|---|
| Package Description | 1 TRAY in 1 CARTON (0173-0893-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER |
|---|
| Product NDC | 0173-0893 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Trelegy Ellipta |
|---|
| Non-Proprietary Name | Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate |
|---|
| Dosage Form | POWDER |
|---|
| Usage | RESPIRATORY (INHALATION) |
|---|
| Start Marketing Date | 20200909 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA209482 |
|---|
| Manufacturer | GlaxoSmithKline LLC |
|---|
| Substance Name | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE |
|---|
| Strength | 200; 62.5; 25 |
|---|
| Strength Unit | ug/1; ug/1; ug/1 |
|---|
| Pharmacy Classes | Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC] |
|---|